Glucagon · source year
4 selected, source-linked Glucagon records carrying a 2019 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
4 selected records.
2 represented types.
4 distinct public records.
Cited chronology
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT02937558 at 2026-07-30T20:42:14.438Z. Its registry update date was 2019-12-10, and PeptideScanner's reviewed identity mapping was glucagon.
Source: ClinicalTrials.gov ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT03533179 at 2026-07-30T20:44:36.691Z. Its registry update date was 2019-10-17, and PeptideScanner's reviewed identity mapping was glucagon.
Source: ClinicalTrials.gov ↗
Regulatory
The official Drugs@FDA dataset lists original submission 1 for NDA 212097 with status AP dated 2019-09-10, and names glucagon among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Regulatory
The official Drugs@FDA dataset lists original submission 1 for NDA 210134 with status AP dated 2019-07-24, and names glucagon among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗